Literature DB >> 6278540

Prostaglandin hyperalgesia, V: a peripheral analgesic receptor for opiates.

S H Ferreira, N Molina, O Vettore.   

Abstract

Prostaglandin E2 injected in the rat paw causes hyperalgesia which is antagonized by local injections of opiate and opiate antagonists. In the present investigation in rats it is shown that naloxone has an analgesic effect at doses as low as 2 micrograms/site, injected into the rat hind paw. At a dose that has no analgesic effect (1 microgram/site) naloxone antagonized the analgesia produced by either local or systemic administration of morphine. Local administration of levorphanol (50 micrograms/site) caused a 50% reduction in the intensity of the hyperalgesia induced by prostaglandin E2. A dose four times greater of its isomer, dextrorphan, had little analgesic effect. The present results support the suggestion that this peripheral analgesia is the result of an action of opiates in receptors located at the nociceptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278540     DOI: 10.1016/0090-6980(82)90021-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  4 in total

1.  Peripheral opioid analgesia in teeth with symptomatic inflamed pulps.

Authors:  R A Uhle; A Reader; R Nist; J Weaver; M Beck; W J Meyers
Journal:  Anesth Prog       Date:  1997

2.  Antinociceptive effects of the novel opioid peptide BW443C compared with classical opiates; peripheral versus central actions.

Authors:  R L Follenfant; G W Hardy; L A Lowe; C Schneider; T W Smith
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

3.  Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear.

Authors:  L Barthó; R Amann; A Saria; J Szolcsányi; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

4.  Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway.

Authors:  Daniela Sachs; Fernando Q Cunha; Sérgio H Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.